Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)

Q: What does CUSIP 00773U108 represent in this 13F holders report?

CUSIP 00773U108 is the security identifier for ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share in Q2 2018?

99 institutional investors reported ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share for Q2 2018. Use the holders table for investor-level position and value details.

CUSIP: 00773U108

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 22,163,711
Total 13F shares: 36,661,531
Share change: +2,234,518
Total reported value: $194,311,714
Put/Call ratio: 27%
Price per share: $5.30
Number of holders: 99
Value change: +$10,169,062
Number of buys: 61
Number of sells: 45

Quarterly Holders Quick Answers

What is CUSIP 00773U108?
CUSIP 00773U108 identifies ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 00773U108:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RENAISSANCE TECHNOLOGIES LLC	13F	Company	17%	3,731,577	$21,643,000	—	31 Mar 2018	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	16%	3,500,000	$20,300,000	—	31 Mar 2018	13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13F	Company	9.5%	2,100,000	$12,180,000	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	9%	1,997,407	$11,585,000	—	31 Mar 2018	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	8.4%	1,870,939	$10,851,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	8.2%	1,817,377	$10,540,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	7.5%	1,668,299	$9,676,000	—	31 Mar 2018	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	6.7%	1,495,097	$8,672,000	—	31 Mar 2018	13F
CITADEL ADVISORS LLC	13F	Company	6.2%	1,374,678	$7,973,000	—	31 Mar 2018	13F
Man Group plc	13F	Company	5.9%	1,306,048	$7,575,000	—	31 Mar 2018	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	5.3%	1,179,192	$6,839,000	—	31 Mar 2018	13F
FMR LLC	13F	Company	4.5%	993,283	$5,761,000	—	31 Mar 2018	13F
Rock Springs Capital Management LP	13F	Company	4.1%	900,000	$5,220,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	3.1%	692,792	$4,019,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	2.9%	634,545	$3,680,000	—	31 Mar 2018	13F
Castle Hook Partners LP	13F	Company	2.6%	577,778	$3,351,000	—	31 Mar 2018	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	2.4%	534,312	$3,099,000	—	31 Mar 2018	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	2.3%	503,400	$2,920,000	—	31 Mar 2018	13F
NEXTHERA CAPITAL LP	13F	Company	2.3%	501,183	$2,907,000	—	31 Mar 2018	13F
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA)	13F	Company	2.2%	480,000	$2,784,000	—	31 Mar 2018	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	1.9%	422,000	$2,448,000	—	31 Mar 2018	13F
Artal Group S.A.	13F	Company	1.8%	400,000	$2,320,000	—	31 Mar 2018	13F
Polar Capital LLP	13F	Company	1.8%	400,000	$2,320,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	1.8%	388,124	$2,251,000	—	31 Mar 2018	13F
PDT Partners, LLC	13F	Company	1.7%	385,700	$2,237,000	—	31 Mar 2018	13F
Casdin Capital, LLC	13F	Company	1.4%	300,000	$1,740,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.3%	281,354	$1,631,000	—	31 Mar 2018	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	1.2%	270,811	$1,571,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	1.2%	257,938	$1,495,000	—	31 Mar 2018	13F
Iguana Healthcare Management, LLC	13F	Company	0.9%	200,000	$1,160,000	—	31 Mar 2018	13F
SABBY MANAGEMENT, LLC	13F	Company	0.9%	198,964	$1,154,000	—	31 Mar 2018	13F
Atika Capital Management LLC	13F	Company	0.88%	195,000	$1,131,000	—	31 Mar 2018	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.85%	189,200	$1,097,000	—	31 Mar 2018	13F
RTW INVESTMENTS, LP	13F	Company	0.79%	175,208	$1,016,000	—	31 Mar 2018	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.77%	171,750	$996,000	—	31 Mar 2018	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.74%	163,580	$949,000	—	31 Mar 2018	13F
BlueCrest Capital Management Ltd	13F	Company	0.72%	159,162	$923,000	—	31 Mar 2018	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.6%	133,031	$772,000	—	31 Mar 2018	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.58%	127,700	$741,000	—	31 Mar 2018	13F
Rhenman & Partners Asset Management AB	13F	Company	0.57%	127,006	$737,000	—	31 Mar 2018	13F
Tibra Equities Europe Ltd	13F	Company	0.49%	108,061	$627,000	—	31 Mar 2018	13F
ELEMENT CAPITAL MANAGEMENT LLC	13F	Company	0.47%	103,900	$603,000	—	31 Mar 2018	13F
ARDSLEY ADVISORY PARTNERS LP	13F	Company	0.45%	100,000	$580,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.45%	99,838	$579,000	—	31 Mar 2018	13F
BARCLAYS PLC	13F	Company	0.43%	95,883	$556,000	—	31 Mar 2018	13F
Alyeska Investment Group, L.P.	13F	Company	0.41%	90,999	$528,000	—	31 Mar 2018	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.36%	80,845	$469,000	—	31 Mar 2018	13F
Invesco Ltd.	13F	Company	0.33%	73,046	$424,000	—	31 Mar 2018	13F
ALGERT GLOBAL LLC	13F	Company	0.33%	72,980	$423,000	—	31 Mar 2018	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.32%	69,891	$405,000	—	31 Mar 2018	13F

Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q2 2018

As of 30 Jun 2018, Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) was held by 99 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,661,531 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., JPMORGAN CHASE & CO, VANGUARD GROUP INC, CITADEL ADVISORS LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, and ALKEON CAPITAL MANAGEMENT LLC. This page lists 99 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.